12/17/2014 - 11:36am

Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.

12/17/2014 - 11:24am

To date, the Food and Drug Administration's Center for Drug Evaluation and Research has approved 35 novel new drugs in 2014, compared to 27 in 2013. 

12/17/2014 - 10:59am

The Generic Pharmaceutical Association on Wednesday expressed concerns that the current structure of the Trans-Pacific Partnership agreement (TPP) will impede generic utilization.

12/17/2014 - 9:20am

McKesson Patient Relationship Solutions on Wednesday announced the successful launch of LoyaltyScript@Retail.

12/16/2014 - 12:24pm

The flu continues to pick up in pockets of the Midwest and across the South, according to the latest Walgreens Flu Index report, a weekly report developed to provide state- and market-specific information regarding flu activity.

12/16/2014 - 11:32am

Use of cigarettes, alcohol and abuse of prescription pain relievers among teens has declined since 2013, while marijuana use rates were stable, according to the 2014 Monitoring the Future survey, released Tuesday.

12/16/2014 - 11:26am

 Greenstone announced the launch of celecoxib — the authorized generic version of Pfizer's Celebrex — to its line of generic pharmaceuticals. 

12/16/2014 - 10:28am

Actavis on Tuesday announced the planned senior management team that will lead the global pharmaceutical company following the successful close of the acquisition of Allergan.

12/16/2014 - 10:27am

Novartis on Tuesday received approval from the Food and Drug Administration for Signifor long-acting release (pasireotide) for injectable suspension, for intramuscular use.